- Home
- ACIU vs WGRX Comparison
ACIU vs WGRX Comparison
Compare ACIU & WGRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACIU
- WGRX
- Stock Information
- Founded
- ACIU 2003
- WGRX 2022
- Country
- ACIU Switzerland
- WGRX United States
- Employees
- ACIU N/A
- WGRX N/A
- Industry
- ACIU Biotechnology: Pharmaceutical Preparations
- WGRX Other Pharmaceuticals
- Sector
- ACIU Health Care
- WGRX Health Care
- Exchange
- ACIU Nasdaq
- WGRX Nasdaq
- Market Cap
- ACIU 168.7M
- WGRX 179.7M
- IPO Year
- ACIU 2016
- WGRX 2025
- Fundamental
- Price
- ACIU $2.07
- WGRX $0.92
- Analyst Decision
- ACIU Strong Buy
- WGRX
- Analyst Count
- ACIU 1
- WGRX 0
- Target Price
- ACIU $12.00
- WGRX N/A
- AVG Volume (30 Days)
- ACIU 119.1K
- WGRX 117.5K
- Earning Date
- ACIU 08-05-2025
- WGRX 08-11-2025
- Dividend Yield
- ACIU N/A
- WGRX N/A
- EPS Growth
- ACIU N/A
- WGRX N/A
- EPS
- ACIU N/A
- WGRX N/A
- Revenue
- ACIU $32,014,254.00
- WGRX $28,992,274.00
- Revenue This Year
- ACIU N/A
- WGRX N/A
- Revenue Next Year
- ACIU $533.21
- WGRX N/A
- P/E Ratio
- ACIU N/A
- WGRX N/A
- Revenue Growth
- ACIU 91.20
- WGRX N/A
- 52 Week Low
- ACIU $1.43
- WGRX $0.90
- 52 Week High
- ACIU $4.37
- WGRX $7.04
- Technical
- Relative Strength Index (RSI)
- ACIU 59.88
- WGRX N/A
- Support Level
- ACIU $1.79
- WGRX N/A
- Resistance Level
- ACIU $2.10
- WGRX N/A
- Average True Range (ATR)
- ACIU 0.17
- WGRX 0.00
- MACD
- ACIU 0.00
- WGRX 0.00
- Stochastic Oscillator
- ACIU 71.93
- WGRX 0.00
About ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses most of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
About WGRX Wellgistics Health Inc. Common Stock
Wellgistics Health Inc is a healthcare technology and pharmaceutical logistics company. It simplifies the logistics of prescription fulfillment from the manufacturer and provider to the patient. It is focused on improving the lives of patients while delivering unique solutions for pharmacies, providers, pharmaceutical manufacturers, and payors.